Impact Factor
4.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
10.77
5,151 total citations
h5-index
83
h5 depth signal
Cited share
93.6%
468 of 500
Total citations
5,151
Citation footprint
Metric signal
12.17
External metric anchor
Self-citation
2.4%
126 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
650
China
355
United Kingdom
263
Sweden
260
Germany
236
Citing Fields of Research
Neurodegenerative Disorders
1,975
Neurosciences
210
Genetics & Genomics
70
Aging & Longevity
41
Medical Ethics
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,417
Articles tracked across the journal lifetime
Indexed publication set
500
468 cited publications
Last 12 months
338
28.2 publications/month
Open access share
100.0%
338 OA publications in the last year
Leading citing country
United States
650 citing publications
Leading citing field
Neurodegenerative Disorders
1,975 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v7n1, 2015-
v1, 2009-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Broad Categories
Neurology
Neurodegenerative Disorders
MeSH Descriptors
Alzheimer Disease
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1186/s13195-026-02235-w
Open DOI
Causal analysis of Alzheimer’s disease molecular data
Background: Genome-wide studies have revealed many molecular associations with Alzheimer’s disease (AD), but association alone does not identify cause, mechanism, or treatable target. This review surveys methods used to infer causal rela...
04
DOI 10.1186/s13195-026-02234-x
Open DOI
Resting-state beta-band oscillatory dysfunction bridges Alzheimer’s pathology and memory impairment
Background: Resting-state electroencephalography (rs-EEG) is a promising non-invasive biomarker of Alzheimer’s disease (AD), yet its role in linking molecular pathology to cognitive impairment remains unclear. We investigated whether rs-...
05
DOI 10.1186/s13195-026-02163-9
Open DOI
Post-hoc analyses of amyloid reduction after one year of treatment with donanemab using clinical trial data: prediction of amyloid clearance and association with downstream measurements
Background: Donanemab is an antibody designed to specifically target modified amyloid that is present only in plaques. An objective of this post hoc study was to identify baseline characteristics associated with 52-week amyloid clearance...
06
DOI 10.1186/s13195-026-02231-0
Open DOI
Integrative clinical–genomic modeling evaluates exploratory Non-APOE candidate signals in Alzheimer’s disease
07
DOI 10.1186/s13195-026-02229-8
Open DOI
Mortality of people with diagnosed dementia in Germany between 2016 and 2021
Background: Germany’s aging population, driven by rising life expectancy and declining birth rates, has resulted in an increasing number of elderly individuals and various health-related challenges, with dementia being one of the most pr...
08
DOI 10.1186/s13195-026-02226-x
Open DOI
IgG depletion by FcRn blockade is associated with changes in amyloid pathology and neurodegeneration in APP/PS1 mice
Background: Autoimmune disorders are associated with an increased risk of developing Alzheimer’s Disease (AD). Dysregulated autoantibodies have been suggested to contribute to exacerbated amyloid-beta (Aβ) accumulation. Based on the pote...
09
DOI 10.1186/s13195-026-02230-1
Open DOI
Microglial dynamics associate with the spatial pattern of tau deposition in early Alzheimer’s disease
Background: Neuroinflammation is implicated in Alzheimer’s disease (AD) pathogenesis, yet how changes in TSPO PET signal are associated with tau deposition, and how brain network architecture shapes this relationship remain poorly unders...
10
Bibliographical & Catalog Notes
Description based on vol. 1, issue 1, July 2009: title from journal information screen.
Latest issue consulted: Vol. 1, issue 1 (July 2009) (viewed Aug. 18, 2009).
Intended as "the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it will publish open access research articles of outstanding quality. Alzheimer's Research & Therapy will publish basic research with a translational focus, as well as clinical trials, and research into drug discovery and development. Although the primary focus is Alzheimer's dementia, the scope will encompass translational research into other neurodegenerative diseases."
Mode of access: World Wide Web.